<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://bharatneeti.com/magellanic-cloud-subsidiary-wins-l1-bid-228-crore/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-22T10:40:24+05:30</news:publication_date>
      <news:title>Magellanic Cloud Subsidiary Wins L1 Bid for ₹228 Crore Bank of Maharashtra E-Surveillance Tender</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/nureca-records-highest-quarterly-revenue-last-20-quarters/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-21T15:57:16+05:30</news:publication_date>
      <news:title>Nureca records highest quarterly revenue in last 20 quarters; Q2 revenue rises 55% to ₹58.53 cr</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/zydus-gets-usfda-nod-hormone-patch-eligible-180-day/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-21T12:45:47+05:30</news:publication_date>
      <news:title>Zydus Gets USFDA Nod for Hormone Patch, Eligible for 180-Day Exclusivity</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/dr-reddys-gets-dcgi-nod-zytorvi-esophageal-cancer/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-21T12:34:48+05:30</news:publication_date>
      <news:title>Dr. Reddy’s Gets DCGI Nod for Zytorvi in Esophageal Cancer</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/transrail-secures-fresh-orders-worth-%e2%82%b9927-crore/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-21T10:45:37+05:30</news:publication_date>
      <news:title>Transrail secures fresh orders worth ₹927 Crore</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/infobeans-technologies-earns-ecovadis-bronze-medal-rated-among/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T18:12:10+05:30</news:publication_date>
      <news:title>InfoBeans Technologies Earns EcoVadis Bronze Medal, Rated Among Top 35% of Companies Assessed Globally</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/sun-pharmas-unloxcyt-earns-category-2a-preferred-designation/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:47:11+05:30</news:publication_date>
      <news:title>Sun Pharma’s UNLOXCYT® Earns Category 2A Preferred Designation in Updated NCCN Guidelines for Advanced Skin Cancer Patients</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://bharatneeti.com/venus-pipes-tubes-accelerates-growth-commences-pipe-spooling/</loc>
    <news:news>
      <news:publication>
        <news:name>Bharat Neeti</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-20T17:27:36+05:30</news:publication_date>
      <news:title>Venus Pipes &amp; Tubes Accelerates Growth, Commences Pipe Spooling Operations Ahead of Schedule</news:title>
    </news:news>
  </url>
</urlset>